Clinical Pharmacy

Posts that discuss a wide range of pharmacy topics with clinical knowledge, references, and experience included!

Clinical Pharmacy

Parkinson’s vs. Parkinsonism: Pharmacotherapy

Accurate differentiation between Parkinson’s disease and other parkinsonian syndromes is key to guiding pharmacotherapy and optimizing patient outcomes.

Members only

Clinical Pharmacy

Updates in the 2025 ATS Community-Acquired Pneumonia Guidelines

Clinical Pharmacy

Myelofibrosis

Myelofibrosis (MF) is a chronic BCR::ABL1-negative myeloproliferative neoplasm (MPN) characterized by clonal myeloid proliferation, bone marrow fibrosis, extramedullary hematopoiesis, and progressive cytopenias.

Clinical Pharmacy

IMforte Journal Club

Overall, this trial was well-designed and provides promising evidence of OS and PFS benefit for patients with extensive-stage SCLC, a historically aggressive disease with poor outcomes

Clinical Pharmacy

Updates in the 2025 ACC/AHA Hypertension Guidelines

The 2025 ACC/AHA hypertension guidelines emphasize earlier detection, lifestyle changes, new PREVENT™ risk tool, and team-based care.

Clinical Pharmacy

Polycythemia Vera

Polycythemia vera (PV) is a Philadelphia chromosome-negative (Ph-) myeloproliferative neoplasm (MPN) characterized by JAK-STAT pathway activation and trilineage myeloproliferation with a predominant increase in red blood cell mass.

Members only

Clinical Pharmacy Featured

Direct Oral Anticoagulant Transitions & Periprocedural Management

Clinical Pharmacy

Corticosteroids: To Taper or Not to Taper

Clinical judgment appears especially crucial when evaluating a patient’s risk of glucocorticoid-induced adrenal insufficiency

Members only

Clinical Pharmacy

First IDSA Guidelines on Complicated UTIs

Clinical Pharmacy

Chronic Graft-Versus-Host Disease (cGVHD)

cGVHD differs fundamentally from acute GVHD and resembles features of autoimmunity and chronic inflammation-driven fibrosis. The pathogenesis includes three overlapping phases.

Clinical Pharmacy

Chagas Disease: A Deadly "Kiss"

Chagas disease, caused by Trypanosoma cruzi, is a serious parasitic infection often overlooked in non-endemic areas, with rising U.S. cases. Join us for this week's discussion on this topic!

Health and Wellness

L-Theanine: An Effective Anxiolytic and Focus-enhancing Supplement?

L-theanine is a naturally occurring amino acid that has been generating buzz for its proposed anxiolytic, focus-enhancing, and sleep-improving effects!

Clinical Pharmacy

Acute Graft-Versus-Host Disease (aGVHD)

Acute graft-versus-host disease (aGVHD) is a major complication of allogeneic hematopoietic stem cell transplantation (allo-HSCT) and a leading cause of non-relapse mortality.

Clinical Pharmacy

It's Getting Hot in Here: Febrile Neutropenia

In today's article, we'll review the basics of FN, risk assessment and ways to assess the severity, and how to treat and manage this life-threatening condition.

Clinical Pharmacy

Hematological Malignancies: Follicular Lymphoma

This article provides a high-level overview of follicular lymphoma (FL), including diagnosis, treatment options, and unmet needs.

Clinical Pharmacy

Penicillin Panic: Are You Really Allergic?

Many penicillin allergy labels are inaccurate, creating barriers to care. Learn how tools like PEN-FAST help de-label and improve treatment.

Members only

Clinical Pharmacy

HIV: Clinical Tips

Members only

Clinical Pharmacy

Let's Talk Vancomycin: Part 2

Clinical Pharmacy

Emergency Medicine Review: TBI Management

Overview of key TBI pharmacotherapy: RSI, sedation, hemodynamics, hyperosmolar therapy, seizure & anticoagulant management for acute care. Robbins 2025 AJEM article discussed.

Clinical Pharmacy

Hematological Malignancies: Diffuse Large B-Cell Lymphoma (DLBCL)

This article provides a high-level overview of the evolution of DLBCL treatment, unmet clinical needs, diagnosis, immunophenotyping, and future therapeutic innovations.

Members only

Clinical Pharmacy

Let's Talk Vancomycin: Part 1

Clinical Pharmacy

Opportunistic Infections: Pneumocystis jirovecii Pneumonia (PJP)

Our first clinical pharmacy article of the year is a high-level overview of pneumocystis jiroveci pneumonia, or PJP (aka PCP). Stay tuned for future opportunistic infection posts!

Health and Wellness

Wearable Wellness: How the Oura Ring May Enhance Patient Care in Pharmacy Practice

By focusing on sleep, health metrics, and activity, the Oura Ring may provide a holistic approach to health tracking.

Paid-members only

Clinical Pharmacy

Aminoglycoside Peak/Trough Interpretations

This past month, I had the pleasure to co-precept a pharmacy resident on an Antimicrobial Stewardship (AMS) rotation. Being a (mostly) outpatient HIV pharmacist for the last 10 months, I was both excited and nervous. What aspects of AMS could I cover from an HIV/outpatient perspective? Oh, how I

Clinical Pharmacy

Finding Nemolizumab in Prurigo Nodularis

Nemolizumab, when administered every 4 weeks, saw a statistically significant improvement in itch relief and IGA treatment success at Week 16, with results as early as 4 weeks, sustained/improvement through Week 24, and a relatively favorable safety profile.